A detailed history of Fsa Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Fsa Advisors, Inc. holds 547 shares of LLY stock, worth $442,036. This represents 0.36% of its overall portfolio holdings.

Number of Shares
547
Previous 485 12.78%
Holding current value
$442,036
Previous $374 Million 20.66%
% of portfolio
0.36%
Previous 0.46%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

BUY
$725.72 - $929.72 $44,994 - $57,642
62 Added 12.78%
547 $452 Million
Q4 2024

Jan 23, 2025

SELL
$727.2 - $932.06 $246,520 - $315,968
-339 Reduced 41.14%
485 $374 Million
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $209,249 - $260,165
-271 Reduced 24.75%
824 $736 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $322,567 - $404,522
445 Added 68.46%
1,095 $918 Million
Q1 2024

May 23, 2024

BUY
$592.2 - $792.28 $384,930 - $514,982
650 New
650 $506 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $768B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fsa Advisors, Inc. Portfolio

Follow Fsa Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fsa Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fsa Advisors, Inc. with notifications on news.